Brown & Brown Releases 2026 Employer Health and Benefits Strategy Survey: Cost Control Takes Center Stage
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Key Terms
stop-loss planfinancial
A stop-loss plan is a predetermined rule an investor sets to automatically sell a stock or other holding when its price falls to a specific level, intended to limit further losses. Think of it like a safety valve or seatbelt: it enforces discipline and helps protect capital by cutting losses before they grow, but it can trigger on short-term swings and may not fully prevent losses in fast-moving markets.
digital health solutionstechnical
Digital health solutions are software, apps, devices and online services that help prevent, monitor, diagnose or manage health conditions — for example, a smartphone app that tracks symptoms or a remote device that sends patient data to clinicians. Investors care because these tools can cut healthcare costs, create recurring revenue streams and scale quickly like a popular app, but their value also depends on user adoption, data privacy safeguards and regulatory approval.
glp-1 drugsmedical
GLP-1 drugs are medicines that mimic a natural gut hormone (glucagon-like peptide-1) to help lower blood sugar and reduce appetite, often used to treat type 2 diabetes and promote weight loss. They matter to investors because they can reshape demand across healthcare — affecting drug sales, medical costs, insurance coverage, and related industries — much like a disruptive new product that changes how people buy and use an everyday item.
prior authorizationregulatory
Prior authorization is a process where a health insurance company requires approval before covering certain medical services or medications. It functions like a pre-approval step, ensuring that the treatment is necessary and appropriate before expenses are paid. For investors, understanding prior authorization is important because delays or denials can impact healthcare costs, provider operations, and the financial stability of related companies.
clinical criteriamedical
Clinical criteria are the specific medical rules, symptoms, test results and measurements used to decide who qualifies for a treatment or clinical trial and to judge whether that intervention is working. Think of them as a clear checklist doctors and regulators use to include or exclude people and to measure success. For investors, these criteria shape how quickly studies enroll, the likelihood of regulatory approval, the size of the potential patient market, and the commercial risk and timeline of a product.
DALLAS--(BUSINESS WIRE)--
Brown & Brown today announced the findings of its second annual Employer Health and Benefits Strategy Survey, 2026, capturing insights from 1,241 employers across the United States. The 2026 edition* reveals a benefits landscape shaped by rising costs, evolving workforce needs and a growing emphasis on innovation and sustainability.
With escalating medical and pharmacy costs, employers have moved cost-containment, for both their organizations and their employees, to the top of their strategic priorities list. In the inaugural 2025 edition of the survey, employers ranked ‘attracting and retaining a competitive workforce’ as their top priority. Some of the popular strategic cost containment initiatives include evaluating stop-loss plan design, conducting audits and partnering with digital health solutions to enhance plan transparency and effectiveness.
Despite the focus on cost control, employers remain committed to supporting employee well-being. A majority (77%) say well-being programs are part of their healthcare strategies, and 78% of this cohort plan to increase related budgets. Parental leave enhancements are also on the rise, with 71% of employers offering paid leave beyond statutory requirements.
“Employers are taking decisive action to manage rising health care costs, from rethinking plan design to adopting digital care solutions and more rigorous pharmacy management strategies,” said Chana Bieker, senior vice president – benefits, national account leader at Brown & Brown. “Amid inflation, economic volatility and shifting social expectations, our survey shows organizations are prioritizing cost control more than ever. At the same, they are utilizing available budget to reinvest in employee well-being in diverse ways, such as more inclusive benefits and expanded parental leave.”
Amidst the ever-growing popularity of GLP-1 drugs for weight loss, the survey also highlights the continued struggle for employers trying to balance access and cost. Nearly half of respondents cover GLP-1s for weight loss (48%), with the vast majority of this respondent group planning to continue coverage over the next one to two years (89%). However, for those that do cover GLP-1s for weight loss, more than six in ten have restrictions in place (63%). A significant percentage of these employers have restrictions beyond prior authorization, such as having to meet certain clinical criteria above and beyond FDA guidelines (49%).
*About the Survey
The second annual Brown & Brown Employer Health and Benefits Strategy Survey, 2026, gathered responses from 1,241 employers. Participating employers had at least 200 employees based in the US. The survey explores a wide array of key strategic issues and opportunities facing employers who sponsored employee health and benefits plans. The survey was fielded from July 31 through September 5, 2025. The margin of error is +/-3%. Download the Executive Summary here https://www.bbrown.com/us/insight/employer-health-and-benefits-strategy-survey-2026/
Upcoming Webinar
Members of the media are invited to join a webinar about the survey results on Wednesday, December 10, 2025, 1:00 – 2:00 pm ET. All registrants will receive a replay link and copy of the presentation.
Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm delivering comprehensive and customized insurance solutions and specialization since 1939. With a global presence spanning 700+ locations and a team of more than 23,000 professionals, we are dedicated to delivering scalable, innovative strategies for our customers at every step of their growth journey. Learn more at BBrown.com.